🔗 Share this article

Texas Attorney General Paxton is suing the makers of Tylenol, asserting the companies withheld safety concerns that the medication posed to children's neurological development.

This legal action arrives a month after Donald Trump promoted an unverified association between consuming acetaminophen - referred to as acetaminophen - during pregnancy and autism spectrum disorder in children.

The attorney general is taking legal action against J&J, which formerly manufactured the medication, the only pain reliever approved for expectant mothers, and the current manufacturer, which presently makes it.

In a declaration, he said they "misled consumers by gaining financially from suffering and promoting medication without regard for the risks."

Kenvue says there is lacking scientific proof connecting acetaminophen to autism spectrum disorder.

"These manufacturers lied for decades, intentionally threatening numerous people to line their pockets," the attorney general, a Republican, declared.

Kenvue stated officially that it was "seriously troubled by the dissemination of inaccurate information on the security of acetaminophen and the potential impact that could have on the welfare of women and children in America."

On its official site, Kenvue also said it had "consistently assessed the pertinent research and there is lacking reliable evidence that indicates a verified association between using paracetamol and autism."

Organizations representing physicians and healthcare providers share this view.

The American College of Obstetricians and Gynecologists has stated acetaminophen - the primary component in acetaminophen - is one of the few options for pregnant women to address discomfort and fever, which can pose significant medical dangers if ignored.

"In multiple decades of studies on the use of paracetamol in gestation, not a single reputable study has successfully concluded that the use of acetaminophen in any period of pregnancy leads to neurodevelopmental disorders in children," the organization stated.

The court filing mentions current declarations from the former administration in arguing the medication is reportedly hazardous.

In recent weeks, Trump caused concern from health experts when he advised pregnant women to "struggle intensely" not to use Tylenol when ill.

Federal regulators then published an announcement that medical professionals should think about restricting the use of acetaminophen, while also declaring that "a direct connection" between the medication and autism in minors has not been established.

The Health Department head RFK Jr, who supervises the FDA, had vowed in spring to undertake "extensive scientific investigation" that would determine the origin of autism spectrum disorder in a short period.

But specialists cautioned that discovering a unique factor of autism - believed by scientists to be the result of a complex mix of genetic and environmental factors - would be difficult.

Autism spectrum disorder is a type of lifelong neurodivergence and impairment that impacts how individuals encounter and interact with the environment, and is recognized using physician assessments.

In his court filing, the attorney general - aligned with the former president who is running for US Senate - claims Kenvue and Johnson & Johnson "willfully ignored and tried to quiet the evidence" around acetaminophen and autism.

This legal action aims to force the firms "eliminate any promotional materials" that states acetaminophen is secure for expectant mothers.

This legal action parallels the complaints of a collection of guardians of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the manufacturers of Tylenol in two years ago.

The court threw out the legal action, stating studies from the plaintiffs' authorities was lacking definitive proof.